MedPath

The Effect of High-Volume Walking With Visual Cues (VC) in Parkinson´s Disease (PD)

Phase 3
Completed
Conditions
Parkinson´s Disease
Interventions
Other: Visual Cues
Other: Walking without visual cues
Registration Number
NCT01391741
Lead Sponsor
University of Iceland
Brief Summary

People with disease (PD) tend to walk with short steps, decreased velocity, and increased stride time variability. Short steps and increased variability are related to greater fall risk. In addition, concurrent performance of a cognitive task (dual-task (DT)) has marked effects on gait in people with PD which is considered to reflect an impaired automaticity of gait.

Objective: To investigate short and long term effects of high-volume walking with visual spatial cues (VSC) on gait variables, automaticity, and functional mobility, in people with Parkinson´s Disease (PD), compared with walking without VSC.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
26
Inclusion Criteria
  • a confirmed diagnosis of PD according to the UK Parkinson´s Disease Society Brain Bank Clinical Diagnostic Criteria (18)
  • <80 years of age
  • community residing
  • Hoehn and Yahr (HY) stage 2-3
  • Mini Mental State Examination (MMSE) score of >23
  • ability to walk without walking aids for a total of 20 minutes over a 30-minute period
Read More
Exclusion Criteria
  • major modifications of Parkinson´s medication (Madopar >200 mg/d or >20% increase in Dopamine agonists) 3 weeks prior to baseline assessment
  • comorbidities or disabilities, which might influence walking
  • a history of brain surgery
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Walking with visual cuesVisual CuesWalking with visual cues for 30 minutes, 4 times a week for 4 weeks
Walking without visual cuesWalking without visual cuesWalking without visual cues, but verbal encouragement twice a week to take longer steps, for 30 minutes, 4 times a week for 4 weeks.
Primary Outcome Measures
NameTimeMethod
Change in Step LengthBefore, after and 3 months after a 4 week training period
Change in Gait VelocityBefore, after and 3 months after a 4 week training period
Change in Stride Time VariabilityBefore, after and 3 months after a 4 week training period
Secondary Outcome Measures
NameTimeMethod
Change in Timed Up & Go (seconds)Before, after and 3 months after a 4 week training period

Trial Locations

Locations (1)

Reykjalundur Rehabilitation Center

🇮🇸

Mosfellsbaer, Iceland

© Copyright 2025. All Rights Reserved by MedPath